Today we have a moderately speculative idea.: take shares of the German chemical company Evonik (ETR: EVK), in order to capitalize on the growth of orders in this area. Growth potential and validity: 13% behind 14 months excluding dividends; 7,5% per annum during 15 years including dividends.
St. Petersburg Stock Exchange has summed up the results of trading in foreign shares in October. Here's how key operating numbers have changed since September: volume of transactions - 31 billion dollars (+15,3%); number of client accounts — 16 million (+8,5%); number of unique clients — 11 million (+8,9%); number of active accounts - 845 thousand (+2,4%). In October, investors traded shares and depositary receipts of 1,626 foreign companies. Here are the most popular ones. Tesla. 21 October, the auto company reported record revenue and profit for the quarter. Revenue was $ 13.8 billion (+57%), net profit — $1.6 billion (+389%). The company has collected 238 thousand cars (+64%), and sold - 241 thousand (+73%). 25 October car rental company Hertz announced the purchase of 100,000 Tesla electric cars worth $ 4.2 billion. After that, Tesla shares rose by 13%, from 910 to 1025 $, and capitalization exceeded a trillion dollars. In total, in October, the company's shares rose by 56%, from 775 to 1208 $. Already in November, Tesla CEO Elon Musk said, that Hertz hurried with the announcement: "The contract has not yet been signed. Demand for Tesla exceeds supply, so we will supply our vehicles to Hertz at the same price, as ordinary buyers". Probably, the parties are still discussing the details and timing of the deal. Alibaba. 4 October, Alibaba share price fell to 140 $ - the minimum for the last three years. Stocks started to fall a year ago, when the Chinese authorities called the company a monopoly. The government later issued a $2.8 billion fine to Alibaba.. So during the year, the company's shares fell by about 50%. In 2021, China interfered with other companies like DiDi, TAL и Tencent. All this had a negative impact on stocks., including Alibaba. So, индекс Nasdaq …
Tesla Stock, Alibaba and Facebook are the most popular among Russian investors Read more
Today we have a moderately speculative idea.: take stock of Genpact (NYSE: G), providing professional services, to capitalize on the inevitable digitalization of the corporate sector. Growth potential and validity: 14% during 12 Months; 11% per year for 15 years. All excluding dividends.
Today we have a very speculative idea: take stock of the manufacturer of 3D printers 3D Systems (NYSE: DDD), in order to capitalize on the expected growth in demand in this area. Growth potential and validity: 20,5% behind 14 Months; 54% behind 4 of the year; 11% per year for 15 years. Why stocks can go up: 3D-seal has a great future.
Severstal (MCX: CHMF, LSE: SVST) — one of the largest metallurgical companies in Russia. About Severstal - a vertically integrated steel company, the main asset of which is the Cherepovets Metallurgical Plant.
Late last week, 4 And 5 november, a lot of interesting things happened in the stock market: one of the pharmaceutical companies has developed an effective cure for coronavirus, tourism companies report good sales, and some last year's beneficiaries disappointed investors.
Tell, how to evaluate securities of banks and insurance companies. The financial sector is one of the largest segments of the S index&P 500, according to market capitalization.
Netflix Reveals Quarterly Financial Results: • Revenue for the quarter increased by 16% up to the mark in $7,48 billion, which turned out to be at the level of expectations. • Net earnings per share amounted to $3,19 (on $0,63 above expectations).
Today we have an extremely speculative idea.: take stock of online commerce software manufacturer BigCommerce Holdings (NASDAQ: BIGC), in order to capitalize on the growth of interest in this sector. Growth potential and validity: 27% behind 16 Months; 56% behind 4 of the year; 15% per annum during 15 years.
PJSC Pharmsintez is one of the few biotechnology companies, whose shares are on the Moscow Exchange. Despite highly inconsistent financials and negative share performance, the company is included in the lists of leading Russian drug manufacturers.